Beilstein Journal of Organic Chemistry 2009, 5, No. 30.
other iodine monochloride (2 mmol, 102 µL) in dry acetonitrile 1H NMR (500 MHz, CDCl3): δ 7.45 (d, 3JHH = 8.7 Hz, 2H,
(4.8 mL). The outlets were connected by standard HPLC tubing H-3/H-5), 7.34 (d, 3JHH = 8.7 Hz, 2H, H-2/H-6) 6.84 (s, 1H,
to a T-junction, after 30 cm tubing a second T-junction was NH) ppm; 13C NMR (125 MHz, CDCl3): δ 154.1 (C-7), 136.0
connected to the third syringe containing the substrate aldehyde (C-4), 132.2 (C-1), 120.9 (C-2/C-6), 117.4 (C-3/C-5) ppm;
(1 mmol) in dry acetonitrile (2.4 mL). All HPLC equipment was EI-MS m/z (%): 242 ([M]+, 100), 240 ([M]+, 96), 231 (25), 229
purchased from CHM GmbH, Fridolfing, Germany. The HPLC (27), 214 (10), 212 (19). HRMS (EI): calc. for C7H5BrN4O:
tubing used as flow reactor was made of PTFE with the meas- 239.9641, found: 239.9639.
urements 1/16 × Ø 0.25 mm. The syringes containing the
reagents were connected to the flow system with PEEK 2,4-Dimethoxyphenylcarbamoyl azide (4d)
adapters (1/4- 28f – Luer, female) and 1/4 PEEK fittings. The The crude product was purified with a silica gel column using
T-mixers used were PEEK (1/4-28 with 1/16 fittings and Ø 0.5 hexane/CH2Cl2 1:4 as eluent. Yield: 47 mg (21%), colourless
mm) for low pressure applications. The third syringe was solid, mp: 65–67 °C.
loaded on a separate syringe pump. The flow rate was adjusted
to an overall flow rate of 7.5 µL/min. The source of heating for 1H NMR (500 MHz, CDCl3): δ 8.02 (d, 3JHH = 8.6 Hz, 1H,
the reaction was a PEG 600 oil bath. After passing the heating H-4), 7.22 (s, 1H, NH), 6.50–6.47 (m, 2H, H-1/H-3), 3.84 (s,
zone (80 °C) behind the second T-junction (4 m) the reaction 3H, H-13 or H-14), 3.80 (s, 3H, H-13 or H-14); 13C NMR (125
was terminated at the outlet with 5 mol% aq thiosulfate solu- MHz, CDCl3): δ 156.7 (C-10), 153.4 (C-2), 149.3 (C-6), 119.9
tion. For work-up, the mixture was extracted with dichloro- (C-4), 109.9 (C-3), 103.9 (C-5), 98.7 (C-1), 55.7 (C-13 or
methane (3 × 10 mL). The combined organic phases were C-14), 55.5 (C-13 or C-14) ppm; EI-MS m/z (%): 222 ([M]+,
separated, dried over magnesium sulfate and the solvent 10), 179 (100), 164 (31), 153 (18), 136 (52), 122 (10), 110 (11),
removed under reduced pressure.
95 (12); HRMS (EI): calc. for C9H10N4O3: 222.0753, found:
222.0755; IR (neat): 1531, 1711, 2144, 3415 cm−1.
Phenylcarbamoyl azide (4a)
The crude product was purified with a silica gel column using Azido(4-bromophenyl)methanone (5)[35]
hexane/CH2Cl2 15:1 as eluent. Yield: 71 mg (44%), colourless The crude product was purified with a silica gel column using
solid, mp: 106–107 °C (lit: 107.1 °C) [18].
hexane/CH2Cl2 1:1 as eluent. Yield: 54 mg (24%), light yellow
solid.
1H NMR (500 MHz, CDCl3): δ 7.44 (d, 3JHH = 7.9 Hz, 1H,
H-2), 7.33 (t, 3JHH = 7.9 Hz, 2H, H-1/H-3), 7.13 (t, 3JHH = 7.4 1H NMR (500 MHz, CDCl3): δ 7.87 (d, 3JHH = 8.8 Hz, 2H,
Hz, 2H, H-4/H-6), 6.97 (s, 1H, NH) ppm; 13C NMR (125 MHz, H-4/H-6), 7.59 (d, 3JHH = 8.8 Hz, 2H, H-1/H-3) ppm; 13C
CDCl3): δ 154.0 (C-8), 136.8 (C-5), 129.2 (C-1/C-3), 124.6 NMR (125 MHz, CDCl3): δ 171.7 (C-8), 132.0 (C-5), 130.8
(C-2), 119.2 (C-4/C-6) ppm; EI-MS m/z (%): 162 ([M]+, 7), 119 (C-1/C-3), 129.7 (C-2), 129.5 (C-4/C-6) ppm.
(100), 93 (64), 91 (56), 64 (32).
N-Phenylpentanamide (6)
4-Chlorophenylcarbamoyl azide (4b)
Phenylcarbamoyl azide 4a (0.12 mmol, 20 mg) was dissolved in
The crude product was purified with a silica gel column using dry THF (35 mL) and cooled to −78 °C under argon. Then
hexane/CH2Cl2 1:1 as eluent. Yield: 63 mg (32%), colourless n-BuLi (0.37 mmol, 0.15 mL, 2.5 M in hexane) was added care-
solid, mp: 103–105 °C.
fully dropwise into the solution via a syringe. After the addition
the cooling bath was removed and the flask was allowed to
1H NMR (500 MHz, CDCl3): δ 7.39 (d, 3JHH = 8.8 Hz, 2H, warm to r.t. The mixture was then diluted with AcOH/THF (20
H-4/H-6), 7.29 (d, 3JHH = 8.8 Hz, 6.86 (s, 1H, NH) ppm; 13C mL/20 mL) and aq sodium carbonate (20 mL). Then
NMR (125 MHz, CDCl3): δ 154.0 (C-9), 135.4 (C-5), 129.8 ethylacetate (60 mL) was added, the organic layer separated and
(C-2), 129.2 (C-1/C-3), 120.4 (C-4/C-6) ppm; EI-MS m/z (%): dried over magnesium sulfate. The crude product was purified
198 ([M]+, 2), 196 ([M]+, 4), 187 (2), 185 (5), 155 (12), 153 with a silica gel column using hexane/CH2Cl2 15:1 as eluent.
(100), 127 (23), 125 (21); HRMS (EI): calc. for C7H535ClN4O: Yield: 14 mg (quant.) colourless solid, mp: 60–61 °C (lit:
196.0146, found: 196.0145.
4-Bromophenylcarbamoyl azide (4c)
1H NMR (500 MHz, CDCl3): δ 7.51 (d, 3JHH = 7.9 Hz, 2H,
The crude product was purified with a silica gel column using H-4/H-6), 7.32 (t, 3JHH = 7.9 Hz, 2H, H-1/H-3), 7.13 (s, 1H,
hexane/CH2Cl2 1:1 as eluent. Yield: 65 mg (27%), colourless NH), 7.10 (t, 3JHH = 7.4 Hz, 1H, H-2), 2.36 (t, 3JHH = 7.6 Hz,
crystals, mp: 77–78 °C.
2H, H-10), 1.72 (qn, 3JHH = 7.6 Hz, 2H, H-11), 1.41 (sext, 3JHH
Page 4 of 6
(page number not for citation purposes)